DGX
Price
$183.49
Change
+$3.38 (+1.88%)
Updated
Sep 5 closing price
Capitalization
20.52B
52 days until earnings call
IQV
Price
$187.68
Change
+$3.60 (+1.96%)
Updated
Sep 5 closing price
Capitalization
31.91B
46 days until earnings call
Interact to see
Advertisement

DGX vs IQV

Header iconDGX vs IQV Comparison
Open Charts DGX vs IQVBanner chart's image
Quest Diagnostics
Price$183.49
Change+$3.38 (+1.88%)
Volume$556.23K
Capitalization20.52B
IQVIA Holdings
Price$187.68
Change+$3.60 (+1.96%)
Volume$1.26M
Capitalization31.91B
DGX vs IQV Comparison Chart in %
Loading...
DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DGX vs. IQV commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGX is a Buy and IQV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (DGX: $183.49 vs. IQV: $187.68)
Brand notoriety: DGX: Not notable vs. IQV: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DGX: 55% vs. IQV: 78%
Market capitalization -- DGX: $20.52B vs. IQV: $31.91B
DGX [@Medical Specialties] is valued at $20.52B. IQV’s [@Medical Specialties] market capitalization is $31.91B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DGX’s FA Score shows that 2 FA rating(s) are green whileIQV’s FA Score has 0 green FA rating(s).

  • DGX’s FA Score: 2 green, 3 red.
  • IQV’s FA Score: 0 green, 5 red.
According to our system of comparison, DGX is a better buy in the long-term than IQV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DGX’s TA Score shows that 5 TA indicator(s) are bullish while IQV’s TA Score has 5 bullish TA indicator(s).

  • DGX’s TA Score: 5 bullish, 4 bearish.
  • IQV’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, IQV is a better buy in the short-term than DGX.

Price Growth

DGX (@Medical Specialties) experienced а +1.02% price change this week, while IQV (@Medical Specialties) price change was -1.64% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.

Reported Earning Dates

DGX is expected to report earnings on Oct 28, 2025.

IQV is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IQV($31.9B) has a higher market cap than DGX($20.5B). IQV has higher P/E ratio than DGX: IQV (26.68) vs DGX (21.97). DGX YTD gains are higher at: 23.381 vs. IQV (-4.493). IQV has higher annual earnings (EBITDA): 3.35B vs. DGX (2.07B). IQV has more cash in the bank: 2.19B vs. DGX (319M). DGX has less debt than IQV: DGX (6.38B) vs IQV (15.7B). IQV has higher revenues than DGX: IQV (15.7B) vs DGX (10.5B).
DGXIQVDGX / IQV
Capitalization20.5B31.9B64%
EBITDA2.07B3.35B62%
Gain YTD23.381-4.493-520%
P/E Ratio21.9726.6882%
Revenue10.5B15.7B67%
Total Cash319M2.19B15%
Total Debt6.38B15.7B41%
FUNDAMENTALS RATINGS
DGX vs IQV: Fundamental Ratings
DGX
IQV
OUTLOOK RATING
1..100
7469
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
70
Overvalued
PROFIT vs RISK RATING
1..100
2884
SMR RATING
1..100
5645
PRICE GROWTH RATING
1..100
3856
P/E GROWTH RATING
1..100
4274
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DGX's Valuation (7) in the Servicestothe Health Industry industry is somewhat better than the same rating for IQV (70). This means that DGX’s stock grew somewhat faster than IQV’s over the last 12 months.

DGX's Profit vs Risk Rating (28) in the Servicestothe Health Industry industry is somewhat better than the same rating for IQV (84). This means that DGX’s stock grew somewhat faster than IQV’s over the last 12 months.

IQV's SMR Rating (45) in the Servicestothe Health Industry industry is in the same range as DGX (56). This means that IQV’s stock grew similarly to DGX’s over the last 12 months.

DGX's Price Growth Rating (38) in the Servicestothe Health Industry industry is in the same range as IQV (56). This means that DGX’s stock grew similarly to IQV’s over the last 12 months.

DGX's P/E Growth Rating (42) in the Servicestothe Health Industry industry is in the same range as IQV (74). This means that DGX’s stock grew similarly to IQV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DGXIQV
RSI
ODDS (%)
Bearish Trend 1 day ago
50%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
66%
Momentum
ODDS (%)
Bearish Trend 1 day ago
48%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bearish Trend 1 day ago
59%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
60%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 20 days ago
60%
Declines
ODDS (%)
Bearish Trend 10 days ago
45%
Bearish Trend 12 days ago
62%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
Bullish Trend 1 day ago
51%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EVN10.680.24
+2.30%
Eaton Vance Municipal Income Trust
PJFM60.32N/A
N/A
PGIM Jennison Focused Mid-Cap ETF
NBFC51.51N/A
N/A
Neuberger Berman Flexible Credit Inc ETF
MAGS61.21-0.12
-0.20%
Roundhill Magnificent Seven ETF
GGT4.27-0.02
-0.47%
THE Gabelli Multimedia Trust

DGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DGX has been loosely correlated with LH. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DGX jumps, then LH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGX
1D Price
Change %
DGX100%
+1.88%
LH - DGX
59%
Loosely correlated
+1.25%
SYK - DGX
43%
Loosely correlated
-0.51%
IQV - DGX
42%
Loosely correlated
+1.96%
MDT - DGX
40%
Loosely correlated
+0.05%
ABT - DGX
40%
Loosely correlated
+0.10%
More

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IQV jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
+1.96%
SYK - IQV
54%
Loosely correlated
-0.51%
ALC - IQV
51%
Loosely correlated
+1.60%
ATR - IQV
50%
Loosely correlated
+0.12%
NVST - IQV
49%
Loosely correlated
+2.55%
QDEL - IQV
48%
Loosely correlated
+3.20%
More